Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

@article{Bowles2012PatientreportedDO,
  title={Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.},
  author={Erin J. Aiello Bowles and Denise M. Boudreau and Jessica Chubak and Onchee Yu and Monica M. Fujii and Janet Chestnut and Diana S. M. Buist},
  journal={Journal of oncology practice},
  year={2012},
  volume={8 6},
  pages={e149-57}
}
BACKGROUND Approximately 20% to 50% of women diagnosed with hormone receptor-positive breast cancer discontinue endocrine therapy early; most reports come from automated pharmacy data or small self-report evaluations. We conducted a larger self-report evaluation of endocrine therapy discontinuation associated with patient characteristics and therapy-related adverse effects. METHODS We surveyed 538 women from a single health plan who were diagnosed with early-stage breast cancer from 2002 to… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 16 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
17 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…